1. R.L. Simmonds, D.M. Canafax, S.D. Fryd, N.L. Asher, W.D. Payne, W. Sutherland and J.S. Narajan, 1986, New immunosuppressive drug combination for mismatched related and cadaveric renal transplant. Transplant. Proc., 18: 76–81.
2. L. Lennard, 1992, The clinical pharmacology of 6-mercaptopurine, Eur. J. Clin. Pharmacol., 43: 329–339.
3. A. Anstey, L. Lennard, S.C. Mayou, J.D. Kirby, 1992, Pancytopenia related to azathioprine an enzyme deficiency caused by a common genetic polymorphism: a review, J. Royal Soc. Med., 85: 752–756.
4. R. Boulieu, A. Lenoir, J.F. Mornex, M. Bertocchi, 1997, Intracellular thiopurine nucleotides and azathioprine myelotoxicity in organ transplant patients, Br. J. Clin. Pharmacol., 43: 116–118.
5. M. Vogt, E. Stet, R. De Abreu, J. Bökkerink, L. Lambooy, J. Trijbels, 1993, The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPr) cytotoxicity in Molt F4 human malignant T lym-phoblasts, Biochem. Biophys. Ada, 1181: 189–194.